KYDES Pharmaceuticals

KYDES Pharmaceuticals, 1450 South Rolling Road, Halethorpe, MD, Tel: +1 410.499.7379

Product Pipeline

KYDES products are developed from currently approved drug compounds and FDA approved excipients using our proprietary technologies. The products will be manufactured to meet or exceed Current Good Manufacturing Practices (CGMP) Guidelines set forth by the FDA and other Regulatory Agencies. The products listed in the menu above are in various stages of development.

Click on the products below for details.

KY1101 & KY1102 KY1103 KY1104 KY1105 KY1106 KY1107

KY1106: Anti-adherent technology

KY006 is an intravenous product with anti-adherent properties being developed as an adjuvant in the treatment of drug resistant malaria, leukemia, sickle cell crisis, chemotherapy-induced micro-thrombosis and drug resistant MRSA/ VRE infections.